BIOT — Bioter SA Cashflow Statement
0.000.00%
- €3.45m
- €192.75m
- €1.26m
Annual cashflow statement for Bioter SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
C2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 6.93 | -8.8 | -9.45 | -12 | -22.1 |
Depreciation | |||||
Non-Cash Items | -18.3 | -0.484 | -0.124 | -0.625 | 14.1 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 2.14 | 2.79 | 0.023 | 6.77 | -3.9 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -9.1 | -6.38 | -9.46 | -5.79 | -11.8 |
Capital Expenditures | — | -0.05 | — | — | -0.214 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0.038 | 1.74 | 0.015 | 0.237 | 0.159 |
Sale of Business | |||||
Sale of Fixed Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 0.038 | 1.69 | 0.015 | 0.237 | -0.055 |
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 9.2 | 4.93 | 9.53 | 8.3 | 9.4 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 0.133 | 0.249 | 0.086 | 2.74 | -2.49 |